Cargando…

Preclinical Efficacy of [V(4)Q(5)]dDAVP, a Second Generation Vasopressin Analog, on Metastatic Spread and Tumor-Associated Angiogenesis in Colorectal Cancer

PURPOSE: Control of metastatic spread of colorectal cancer (CRC) remains as a major therapeutic challenge. [V4 Q5 ]dDAVP is a vasopressin peptide analog with previously reported anticancer activity against carcinoma tumors. By acting as a selective agonist of arginine vasopressin type 2 membrane rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garona, Juan, Sobol, Natasha T., Pifano, Marina, Segatori, Valeria I., Gomez, Daniel E., Ripoll, Giselle V., Alonso, Daniel F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473275/ https://www.ncbi.nlm.nih.gov/pubmed/29879760 http://dx.doi.org/10.4143/crt.2018.040

Ejemplares similares

The novel desmopressin analogue [V(4)Q(5)]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models
por: GARONA, JUAN, et al.
Publicado: (2015)

Vasopressin Analog [V(4)Q(5)]dDAVP Exerts Cooperative Anticancer Effects in Combination With Low-Dose 5-Fluorouracil on Aggressive Colorectal Cancer Models
por: Sobol, Natasha T., et al.
Publicado: (2023)

Commentary: Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer
por: Ripoll, Giselle V., et al.
Publicado: (2020)

Peptide Agonists of Vasopressin V2 Receptor Reduce Expression of Neuroendocrine Markers and Tumor Growth in Human Lung and Prostate Tumor Cells
por: Pifano, Marina, et al.
Publicado: (2017)

Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model
por: Ripoll, Giselle V., et al.
Publicado: (2013)

dDAVP Downregulates the AQP3-Mediated Glycerol Transport via V1aR in Human Colon HCT8 Cells
por: Centrone, Mariangela, et al.
Publicado: (2022)

Administration of the vasopressin analog desmopressin for the management of bleeding in rectal cancer patients: results of a phase I/II trial
por: Iseas, Soledad, et al.
Publicado: (2020)

Vasopressin Bolus Protocol Compared to Desmopressin (DDAVP) for Managing Acute, Postoperative Central Diabetes Insipidus and Hypovolemic Shock
por: Shukla, Anukrati, et al.
Publicado: (2017)

Anticancer activity of repurposed hemostatic agent desmopressin on AVPR2-expressing human osteosarcoma
por: Sobol, Natasha Tatiana, et al.
Publicado: (2021)

A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients
por: Weinberg, Ruth S, et al.
Publicado: (2015)

DDAVP Might Reduce the Risk of Preeclampsia in Pregnant Women with VWF Deficiency
por: Jahromi, Alireza Hamidian, et al.
Publicado: (2013)

Coronary Spastic Angina Induced after Oral Desmopressin (DDAVP) Administration
por: Adachi, Yusuke, et al.
Publicado: (2016)

SUN-410 Central Diabetes Insipidus Refractory to Oral Desmopressin (DDAVP)
por: Burdea, Liliana, et al.
Publicado: (2019)

Propranolol blocks osteosarcoma cell cycle progression, inhibits angiogenesis and slows xenograft growth in combination with cisplatin-based chemotherapy
por: Solernó, Luisina M., et al.
Publicado: (2022)

Administration of DDAVP did not improve the pharmacokinetics of FVIII concentrate in a clinically significant manner
por: Loomans, Janneke I, et al.
Publicado: (2018)

MON-435 The Responsiveness To Ddavp Test Predicts Usp8 Mutation In Patients With Cushing's Disease
por: Shichi, Hiroki, et al.
Publicado: (2019)

cAMP-Epac1 signaling is activated in DDAVP-induced endolymphatic hydrops of guinea pigs
por: Chuan, Wang, et al.
Publicado: (2023)

Vasopressin analog terlipressin attenuates kidney injury in hemorrhagic shock
por: Cardoso de Castro, Letícia Urbano, et al.
Publicado: (2016)

Treatment with ddAVP improves platelet-based coagulation in a rat model of traumatic hemorrhagic shock
por: Wirtz, Mathijs R, et al.
Publicado: (2022)

Low COAT platelets are frequent in patients with bleeding disorders of unknown cause (BDUC) and can be enhanced by DDAVP
por: Segot, Amandine, et al.
Publicado: (2022)

An Early Look at the Therapeutic Uses of Some New Vasopressin Analogs in Gastroenterology
por: Cort, Joseph H., et al.
Publicado: (1978)

Vasopressin and Vasopressin Receptor Antagonists
por: Oh, Yun Kyu
Publicado: (2008)

Home blood sodium monitoring, sliding-scale fluid prescription and subcutaneous DDAVP for infantile diabetes insipidus with impaired thirst mechanism
por: Hameed, Shihab, et al.
Publicado: (2012)

Pitfalls in Interventional Pain Medicine: Hyponatremia after DDAVP for a Patient with Von Willebrand Disease Undergoing an Epidural Steroid Injection
por: Khan, Talal W., et al.
Publicado: (2017)

Pro‐haemostatic effect of DDAVP is partially derived through non‐classical (CD14(dim) /CD16 (++)) monocytes residing the spleen
por: Salarilak, Laleh, et al.
Publicado: (2022)

The Functional Interaction between Acyl-CoA Synthetase 4, 5-Lipooxygenase and Cyclooxygenase-2 Controls Tumor Growth: A Novel Therapeutic Target
por: Orlando, Ulises D., et al.
Publicado: (2012)

Role of the Vasopressin/Apelin Balance and Potential Use of Metabolically Stable Apelin Analogs in Water Metabolism Disorders
por: Flahault, Adrien, et al.
Publicado: (2017)

Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancer
por: Segatori, Valeria I., et al.
Publicado: (2012)

Effect of Ivermectin and Atorvastatin on Nuclear Localization of Importin Alpha and Drug Target Expression Profiling in Host Cells from Nasopharyngeal Swabs of SARS-CoV-2- Positive Patients
por: Segatori, Valeria Inés, et al.
Publicado: (2021)

Comparison of the pharmacologic profiles of arginine vasopressin and oxytocin analogs at marmoset, titi monkey, macaque, and human oxytocin receptors
por: Pierce, Marsha L., et al.
Publicado: (2020)

Vasopressin Is No Inotrope
por: Roeleveld, Peter Paul
Publicado: (2018)

The Biology of Vasopressin
por: Sparapani, Samantha, et al.
Publicado: (2021)

Preclinical efficacy of CIGB-300, an anti-CK2 peptide, on breast cancer metastasic colonization
por: Gottardo, Maria F., et al.
Publicado: (2020)

Rethinking Vasopressin: New Insights into Vasopressin Signaling and Its Implications
por: Watts, Jason A., et al.
Publicado: (2023)

Expression of bladder cancer-associated glycans in murine tumor cell lines
por: Albertó, Marina, et al.
Publicado: (2019)

Spreading depression as a preclinical model of migraine
por: Harriott, Andrea M., et al.
Publicado: (2019)

Measurement of the Q spread in CESAR
por: Ruggiero, A G
Publicado: (1966)

Recent advances and future directions in preclinical research of arginine-vasopressin (AVP) receptor blocker conivaptan in the context of stroke
por: Zeynalov, Emil, et al.
Publicado: (2016)

Central vasopressin: dendritic and axonal secretion and renal actions
por: Bichet, Daniel G.
Publicado: (2014)

Clinical Efficiency of Vasopressin or Its Analogs in Comparison With Catecholamines Alone on Patients With Septic Shock: A Systematic Review and Meta-Analysis
por: Yao, Ren-qi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tb64gafq4rcc34ft42krctpfn4